Latest Ratios: P/E Ratio 285.0x · EV/EBITDA N/A · ROE 11.2%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $204M | $438M | $431M | $401M | $541M | $575M | $578M | $392M | $653M | $383M | $165M |
| Enterprise Value | $50M | $283M | $276M | $252M | $443M | $472M | $460M | $407M | $628M | $434M | $203M |
| P/E Ratio → | 285.00 | 18.52 | 7.24 | 5.89 | 16.00 | 8.26 | 10.24 | — | 1.55 | — | — |
| P/S Ratio | 3.90 | 4.62 | 3.11 | 2.87 | 4.89 | 4.30 | 4.62 | 14.66 | 1.37 | 31.18 | 10.99 |
| P/B Ratio | 1.03 | 2.20 | 2.00 | 2.04 | 3.18 | 3.30 | 4.45 | 4.01 | 6.35 | — | — |
| P/FCF | — | 10.15 | 8.85 | 4.24 | 13.01 | 50.21 | 8.08 | — | 9.50 | — | — |
| P/OCF | 4.70 | 10.06 | 8.85 | 4.23 | 13.01 | 49.98 | 8.07 | — | 9.49 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.99 | 1.99 | 1.80 | 4.00 | 3.53 | 3.68 | 15.23 | 1.32 | 35.35 | 13.51 |
| EV / EBITDA | — | 11.67 | 3.92 | 2.99 | 10.25 | 5.27 | 5.41 | — | 1.77 | — | — |
| EV / EBIT | 2.11 | 9.31 | 3.63 | 2.87 | 10.04 | 5.28 | 6.01 | 72.83 | 1.47 | — | — |
| EV / FCF | — | 6.57 | 5.67 | 2.66 | 10.65 | 41.23 | 6.43 | — | 9.14 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 68.6% | 68.6% | 77.4% | 87.3% | 90.6% | 87.6% | 79.4% | 43.6% | 77.3% | -36.0% | -31.5% |
| Operating Margin | 25.1% | 25.1% | 50.4% | 59.8% | 38.5% | 66.7% | 67.6% | -8.7% | 74.4% | -153.6% | -206.9% |
| Net Profit Margin | 24.6% | 24.6% | 42.7% | 48.6% | 30.6% | 52.0% | 45.1% | -27.1% | 88.4% | -295.3% | -264.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.2% | 11.2% | 28.7% | 37.1% | 19.7% | 45.7% | 49.5% | -7.2% | 409.9% | — | — |
| ROA | 10.0% | 10.0% | 23.7% | 30.3% | 16.5% | 38.1% | 32.3% | -3.6% | 242.3% | -23.7% | -22.9% |
| ROIC | 33.7% | 33.7% | 97.0% | 105.3% | 44.6% | 159.1% | 101.1% | -1.8% | 342.3% | — | — |
| ROCE | 11.3% | 11.3% | 33.4% | 44.7% | 23.9% | 55.1% | 68.7% | -1.6% | 215.2% | -13.2% | -19.1% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.82 | 0.73 | — | — |
| Debt / EBITDA | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | — | 0.21 | — | — |
| Net Debt / Equity | — | -0.78 | -0.72 | -0.76 | -0.58 | -0.59 | -0.90 | 0.16 | -0.24 | — | — |
| Net Debt / EBITDA | -6.36 | -6.36 | -2.20 | -1.78 | -2.27 | -1.15 | -1.38 | — | -0.07 | — | — |
| Debt / FCF | — | -3.58 | -3.18 | -1.58 | -2.36 | -8.97 | -1.64 | — | -0.37 | — | — |
| Interest Coverage | — | — | — | — | — | — | 25.37 | 0.35 | 27.59 | -1.60 | -1.82 |
Net cash position: cash ($155M) exceeds total debt ($595169)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.83 | 11.83 | 9.12 | 4.42 | 8.63 | 6.85 | 13.70 | 1.96 | 10.70 | 5.49 | 5.00 |
| Quick Ratio | 9.10 | 9.10 | 7.16 | 3.23 | 6.81 | 6.21 | 11.77 | 1.86 | 10.44 | 5.05 | 3.11 |
| Cash Ratio | 8.61 | 8.61 | 6.13 | 2.77 | 4.59 | 3.38 | 11.25 | 0.71 | 8.88 | 2.92 | 2.08 |
| Asset Turnover | — | 0.43 | 0.57 | 0.55 | 0.57 | 0.62 | 0.83 | 0.13 | 2.34 | 0.08 | 0.09 |
| Inventory Turnover | 0.61 | 0.61 | 0.63 | 0.28 | 0.27 | 0.85 | 1.27 | 1.56 | 37.23 | 5.59 | 0.75 |
| Days Sales Outstanding | — | 12.59 | 55.69 | 55.12 | 149.61 | 228.42 | 9.76 | 56.89 | 1.50 | 53.61 | 76.82 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 21.1% | 9.9% | 9.9% | 8.0% | 6.1% | — | — | — | — | — | — |
| Payout Ratio | — | — | — | 47.2% | 97.2% | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 0.4% | 5.4% | 13.8% | 17.0% | 6.3% | 12.1% | 9.8% | — | 64.6% | — | — |
| FCF Yield | — | 9.9% | 11.3% | 23.6% | 7.7% | 2.0% | 12.4% | — | 10.5% | — | — |
| Buyback Yield | 0.2% | 0.1% | 0.2% | 2.8% | 2.4% | 4.5% | 4.9% | 0.0% | 0.6% | 0.2% | 0.3% |
| Total Shareholder Yield | 21.3% | 10.0% | 10.1% | 10.8% | 8.5% | 4.5% | 4.9% | 0.0% | 0.6% | 0.2% | 0.3% |
| Shares Outstanding | — | $72M | $72M | $72M | $74M | $76M | $79M | $82M | $83M | $79M | $57M |
Includes 30+ ratios · 30 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SIGA stock.
SIGA Technologies, Inc.'s current P/E ratio is 285.0x. The historical average is 12.0x. This places it at the 100th percentile of its historical range.
SIGA Technologies, Inc.'s return on equity (ROE) is 11.2%. The historical average is -76.9%.
Based on historical data, SIGA Technologies, Inc. is trading at a P/E of 285.0x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
SIGA Technologies, Inc.'s current dividend yield is 21.13%.
SIGA Technologies, Inc. has 68.6% gross margin and 25.1% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
SIGA Technologies, Inc.'s Debt/EBITDA ratio is 0.0x, indicating low leverage. A ratio below 2x is generally considered financially healthy.
Key Metrics
Top Statement Risk
Contract-lumpiness distorting all ratios
Metrics are mathematically derived from official filings.
Depressed Multiples Reflect Earnings Doubt
SIGA trades at a 9.70x trailing P/E and 3.10x EV/EBITDA versus Gilead's 14.86x, per current market multiples, yet the 1.88x forward P/E and 18.8% dividend yield suggest the market prices these earnings as non-recurring rather than a compounding stream.
The 1.15x price-to-book ratio, well below Gilead's 8.83x, appears consistent with a business whose $175.7M asset base generates volatile rather than durable returns, and the deep discount to large-cap specialty pharma peers may indicate investors treat SIGA's contract wins as episodic. A 5.32x P/FCF alongside a 9.70x P/E implies the market sees cash conversion as more dependable than accounting earnings, which is plausible given working-capital swings dominate SIGA's reported cash flows. The forward P/E of 1.88x should be treated as an artifact of a single strong projected quarter, not a normalized earnings power estimate; if backlog does not replenish, both trailing and forward multiples could re-rate sharply higher on shrinking denominators.
Returns Swing, Not Compound
As SIGA's quarterly ratio table shows, ROIC has swung from 83.7% in 2025Q2 to -25.6% in 2025Q3, with 38.3% in 2026Q2, indicating returns are driven by shipment recognition timing rather than a steadily compounding capital base.
With essentially no debt (0.00 debt-to-equity), ROE and ROA largely track the same earnings volatility—ROE ranged from 23.8% to -3.1%—so the equity return figure adds little independent signal about financial engineering. Asset turnover of 0.01x to 0.37x confirms that the return swings originate almost entirely in the margin line, not capital efficiency, which would be the hallmark of a genuine compounding franchise. Investors should note that the 38.3% ROIC in 2026Q2 was earned on a base that has shrunk 28.5% from its 2025Q1 peak, so headline returns may flatter a decaying rather than expanding invested-capital base.
Margins Track Cost Absorption, Not Pricing
Reported margins span from a -8.1% gross margin in 2026Q2 to 97.8% in 2025Q1, per SIGA's ten-quarter ratio data, while net margin reached 56.2% in 2024Q4—swings that appear to reflect cost absorption timing more than structural pricing power.
The 2026Q2 print is internally revealing: a negative gross margin coexists with a 33.9% operating margin and 30.4% net margin, implying that reported profitability that quarter rested substantially on non-operating items rather than the core manufacturing franchise. The absence of meaningful stock-based compensation relative to peak net income (under $2.0M quarterly versus $45.8M) means the swings are not an adjustment artifact, but the fixed-cost structure identified in the income statement analysis means margin quality in any single quarter is a poor guide to mid-cycle earning power. A trough-quarter net margin of -55.3% in 2026Q1 against a peak of 56.2% suggests the truest measure of earning power is a multi-quarter average, which currently sits far below headline peak figures.
Inventory Stockpile Drives Cycle Extreme
Based on SIGA's quarterly working-capital ratios, the cash conversion cycle has ranged from 172 days in 2025Q2 to over 30,000 days in 2025Q1, with inventory days above 1,400 in the two most recent quarters, pointing to stockpile build awaiting episodic shipments.
Days payable of 90 to 112 in recent quarters are modest and stable, indicating supplier terms are not the volatile element; the swing factor is inventory, which at 1,510 days in 2026Q2 appears to reflect strategic stockholding of finished TPOX/medical countermeasure product rather than operational inefficiency in the classic sense. Receivables management looks comparatively disciplined at 13 days in 2026Q2, suggesting that once SIGA ships, collection is swift—likely because buyers are government or large institutional counterparties. The efficiency picture therefore reads as a deliberate inventory-against-lumpy-demand model, and investors should monitor whether inventory days normalize toward the 169-day level of 2025Q2, which would signal shipments catching up to the stockpile.
Cash Fortress Offsets Shrinking Equity
SIGA's current ratio of 21.72x and quick ratio of 16.48x in 2026Q2, alongside a 0.00 debt-to-equity ratio, per reported balance-sheet ratios, indicate liquidity far beyond operating requirements, sustained by accumulated cash rather than a dependable recurring cash-generation engine.
Under severe stress, the profile appears resilient: no debt maturities service, a quick ratio nearly matching the current ratio (implying little inventory dependence for near-term coverage), and $117.6M of cash against $175.7M of total assets. However, the current ratio dipped to 3.25x in 2026Q1 and 3.05x in 2024Q1, so the liquidity floor is a function of when large receipts land rather than a structurally stable buffer. The tension investors should weigh is that this fortress coexists with an accumulated deficit that widened $54.8M in five quarters and lump-sum dividends totaling roughly $128.9M over ten quarters—the liquidity cushion is real today, but its persistence depends on contract timing and continued willingness to distribute.
P/E Misreads Lumpy Government Contracts
The 9.70x trailing P/E is the ratio most likely misapplied to SIGA, given net margin swung from 56.2% to -55.3% within four quarters; EV less net cash, or backlog coverage of the fixed-cost base, offers a more durable valuation anchor.
Because SIGA's earnings are concentrated in quarters where large orders ship—2024Q4 and 2025Q2 carried the ten-period profits while intervening quarters ran losses—a trailing earnings multiple simultaneously understates normalized value in trough quarters and overstates durability in peak quarters. EV/EBITDA of 3.10x suffers a similar distortion, since EBITDA itself is quarterly-lumpy, and even price-to-book at 1.15x may mislead: the book value is being drawn down by dividends rather than operations, so the multiple's denominator is not stable. The more informative framing, consistent with the zero-debt balance sheet, is the enterprise value relative to net cash plus an assessment of whether announced orders replenish the backlog quickly enough to cover overhead, a question the deferred revenue zero-print in 2026Q2 leaves open.